DexCom, Inc. vs Utilities Select Sector SPDR Fund — how do they compare? DexCom, Inc. trades at $84.39 (market cap $31.86B), while Utilities Select Sector SPDR Fund trades at $41.17 (market cap $23.60B). The key difference: DexCom, Inc. is the larger of the two by market cap, and DexCom, Inc. is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| DXCM | XLU | |
|---|---|---|
Market Cap | $31.86B | $23.60B |
Volume | 3,607,070 | 28,758,237 |
Sector | Health | — |
52-Week High | $92.34 | $47.73 |
52-Week Low | $54.84 | $39.25 |
Typical Hold Time | 62 Days | 80 Days |
Enterprise Value | $31.32B | — |
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $84.3, up 1.09% today, with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 EPS of $0.70, beating estimates, continuing a trend of earnings outperformance. Revenue growth is robust, with 2025 revenue reaching $4.66 billion and net income margin improving to 20.12%. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target, suggesting significant upside from current levels.
The outlook for DXCM is positive driven by expansion in continuous glucose monitoring for Type 2 diabetes, as highlighted in recent company reports. Key risks include competitive pressures and reimbursement challenges. With solid cash flow generation and institutional support, the stock presents a growth opportunity, though investors should monitor execution against high expectations.
XLU trades at $41.09, down 0.15% with mixed technical signals showing a bullish moving average trend but neutral oscillators. The ETF recently hit 52-week lows amid sector-wide pressure from rising interest rates. Support levels cluster around $40-41 while resistance sits at $41-42. Recent news highlights utility stocks as oversold with potential defensive appeal during market volatility.
The outlook remains cautious given interest rate sensitivity, though current levels may offer value for defensive positioning. Key risks include further rate hikes and AI power demand uncertainty. Analyst sentiment is divided with technical indicators suggesting near-term consolidation potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →